SCHOTT PHARMA AG& CO KGAA

Discover SCHOTT Pharma’s leading drug containment and delivery solutions, from prefillable syringes to full CDMO services, driving growth in global pharma.

Schott Pharma’s 2026 Q3 surge and upward revenue outlook boost shares, showing strong drug‑delivery growth and solid future value for life‑science investors.

Schott Pharma’s stock soars after Deutsche Bank lifts target to €22, citing stronger ops in H2 and growing injection‑system demand.